1246471-79-3 Usage
Uses
Used in Pharmaceutical Industry:
2-Bromo-5-nitro-1H-indole-3-carbaldehyde serves as an intermediate in the synthesis of pharmaceuticals, contributing to the development of various medicines. Its role in this industry is pivotal due to its ability to facilitate the creation of complex drug molecules.
Used in Fine Chemicals Synthesis:
2-Bromo-5-nitro-1H-indole-3-carbaldehyde is also utilized as an intermediate in the production of other fine chemicals, indicating its versatility in chemical reactions and its importance in a broad spectrum of chemical applications.
Used in Dye and Pigment Manufacturing:
2-Bromo-5-nitro-1H-indole-3-carbaldehyde finds application in the manufacturing of dyes and pigments, where its chemical properties are harnessed to produce a range of colorants for different industries.
Each of these uses underscores the compound's significance in diverse sectors, highlighting its multifaceted role in both the creation of life-saving pharmaceuticals and the production of vibrant dyes and pigments.
Check Digit Verification of cas no
The CAS Registry Mumber 1246471-79-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,6,4,7 and 1 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1246471-79:
(9*1)+(8*2)+(7*4)+(6*6)+(5*4)+(4*7)+(3*1)+(2*7)+(1*9)=163
163 % 10 = 3
So 1246471-79-3 is a valid CAS Registry Number.
1246471-79-3Relevant academic research and scientific papers
INHIBITORS OF HEPATITIS C VIRUS REPLICATION
-
Paragraph 0849-0850, (2019/05/15)
The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.
INHIBITORS OF HEPATITIS C VIRUS REPLICATION
-
Page/Page column 137, (2010/11/04)
The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.
